Furthermore, we used The Cancer Genome Atlas (TCGA)-LIHC database to analyze the expression patterns and clinical characteristics of cellular senescence-related genes and identified CDK1, CDK4, CHEK1, and G6PD as key therapeutic molecular targets in EZW-suppressed HCC. The gene discussed is CHEK1; the disease is hepatocellular carcinoma.